疫苗协会重任在肩，博沃生物砥砺前行。

近日，上海博沃生物执行董事、武汉博沃生物CEO吴克博士收到了中国疫苗行业协会(China Association for Vaccines, CAV)颁发的中国疫苗行业协会糖疫苗专业委员会第一届委员会副主任委员聘书，聘期4年。

Recently, Dr. Wu Ke, CEO of BravoBio, received the Letter of Appointment from CAV as the “Vice Chairman of the First Session of Saccharide Vaccine Committee of China Association for Vaccines” with employment term of 4 years.

作为中国疫苗行业协会（CAV）的成员，博沃生物将秉承CAV宗旨，加强与协会和成员单位的互动交流，推进各疫苗管线研发和生产的制度化、规范化、标准化，确保疫苗的稳定性、安全性、有效性，为中国人民和世界人民提供优质及负担得起的疫苗产品。

As a member of CAV, BravoVax (subcompany of BravoBio）will uphold the CAV purpose, enhance the communications with the association and member units, promote the standardization of R&D and production of vaccine pipelines, ensure the stability, safety and effectiveness of vaccines, and provide affordable vaccines with high quality for people all over the world.

关于中国疫苗行业协会

About China Association for Vaccines(CAV)

2019年9月2日，民政部批准中国医药企业发展促进会更名为中国疫苗行业协会，在推动加强疫苗行业自律、引导企业依法开展生产经营等方面发挥更加积极的作用。

CAV 现有会员单位331家，分支机构33个。涵盖我国主要疫苗企业与生物制品企业，以及为疫苗及生物制品研发、生产、流通配套服务的上下游企业，贯穿生物制药全产业链和不同业务领域。

CAV 的宗旨是服务健康中国战略，坚持以人民为中心、始终把人民的身体健康放在首位的发展理念，促进疫苗及其相关生物制品行业发展。积极参与行业安全治理，建立健全行业自律规范，推动行业诚信体系建设，引导和督促企业依法开展生产经营等活动，促进全行业自我管理、自我规范、自我净化、自我提高。加强行业与政府的沟通协调、促进产业政策与相关法规贯彻落实，维护会员合法权益、维护公平竞争与市场秩序，积极推动科技创新、优化资源配置、提升产品及服务质量、促进产业升级。

China Association for Vaccines(CAV) was founded in September 2, 2019. It plays an important role in enhancing self-discipline of the vaccine industry, offering the guidance to enterprises in production and operation in accordance with the law.

CAV now has 331 members and 33 divisions, covering the major vaccine and biological products enterprises in China , as well as the upstream and downstream enterprises in the research and development, production and distribution of vaccines and biological products, and running through the whole bio-pharmaceutical industry chain.

The purpose of the association is to serve the healthy China strategy, adhere to the people-centered development concept, always put people's health in the first place, and promote the development of vaccines and related biological products industry. Actively participate in the safety management of vaccines and biological products, establish and improve industry self-discipline standards, promote the construction of industry integrity system, guide and urge enterprises to carry out production and operation activities in accordance with the law, and promote self-management, self-regulation, self-purification and self-improvement of the whole industry. Strengthen communication and coordination between the industry and the government, expedite the implementation of industrial policies and relevant laws and regulations, safeguard the legitimate rights and interests of members, maintain fair competition and market order, actively promote scientific and technological innovation, optimize the allocation of resources, improve the quality of products and services, and promote industrial upgrading.